These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31272240)

  • 41. A Number of Cases in Iran Presenting with Coinheritance of Hemoglobin-H Disease and Beta-Thalassemia Minor.
    Zarei T; Dehbozorgian J; Imanifard J; Setoodegan F; Karimi M
    Hemoglobin; 2016 Sep; 40(5):316-318. PubMed ID: 27535574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extended molecular spectrum of beta- and alpha-thalassemia in Oman.
    Hassan SM; Hamza N; Jaffer Al-Lawatiya F; Jaffer Mohammed A; Harteveld CL; Rajab A; Giordano PC
    Hemoglobin; 2010 Jan; 34(2):127-34. PubMed ID: 20353347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Scanning of β-Thalassemia in the Southern Region of Central Java, Indonesia; a Step Towards a Local Prevention Program.
    Rujito L; Basalamah M; Mulatsih S; Sofro AS
    Hemoglobin; 2015; 39(5):330-3. PubMed ID: 26291967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. β-globin genes: mutation hot-spots in the global thalassemia belt.
    Kumar R; Sagar C; Sharma D; Kishor P
    Hemoglobin; 2015; 39(1):1-8. PubMed ID: 25523871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thalassemia in Iran: epidemiology, prevention, and management.
    Abolghasemi H; Amid A; Zeinali S; Radfar MH; Eshghi P; Rahiminejad MS; Ehsani MA; Najmabadi H; Akbari MT; Afrasiabi A; Akhavan-Niaki H; Hoorfar H
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):233-8. PubMed ID: 17414565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin.
    Huang Y; Long Y; Deng D; Liu Z; Liang H; Sun N; Xu Y; Lai Y; Cheng P
    Thromb Res; 2018 Dec; 172():61-66. PubMed ID: 30384036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Beta-thalassemia and Hb D in patients with anemia].
    Troĭtskaia OV; Antonova LA; Lozhechnik IG; Toshchan OV
    Klin Lab Diagn; 1998 Mar; (3):16-23. PubMed ID: 9575728
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Tamaddoni A; Khabaz Astaneh S; Tabaripour R; Akhavan-Niaki H
    Hemoglobin; 2019 Jan; 43(1):12-17. PubMed ID: 30747024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
    Balgir RS
    J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of occult hepatitis C virus infection in Iranian patients with beta thalassemia major.
    Bastani MN; Bokharaei-Salim F; Keyvani H; Esghaei M; Monavari SH; Ebrahimi M; Garshasebi S; Fakhim S
    Arch Virol; 2016 Jul; 161(7):1899-906. PubMed ID: 27132015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of iron deficiency anemia and hemoglobinopathies among college students and pregnant women: a multi center evaluation in India.
    Mohanty D; Gorakshakar AC; Colah RB; Patel RZ; Master DC; Mahanta J; Sharma SK; Chaudhari U; Ghosh M; Das S; Britt RP; Singh S; Ross C; Jagannathan L; Kaul R; Shukla DK; Muthuswamy V
    Hemoglobin; 2014; 38(4):252-7. PubMed ID: 25023086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of intelligence quotient in patients with homozygous beta-thalassemia.
    Karimi M; Yarmohammadi H; Cappellini MD
    Saudi Med J; 2006 Jul; 27(7):982-5. PubMed ID: 16830015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular spectrum of beta-thalassemia mutations in Northwestern Iran.
    Hosseinpour Feizi MA; Hosseinpour Feizi AA; Pouladi N; Haghi M; Azarfam P
    Hemoglobin; 2008; 32(3):255-61. PubMed ID: 18473241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sistani population: a different spectrum of β-thalassemia mutations from other ethnic groups of Iran.
    Miri-Moghaddam E; Zadeh-Vakili A; Nikravesh A; Sistani SS; Naroie-Nejad M
    Hemoglobin; 2013; 37(2):138-47. PubMed ID: 23437895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Epidemiology of Hemoglobinopathies in Cambodia.
    Munkongdee T; Tanakulmas J; Butthep P; Winichagoon P; Main B; Yiannakis M; George J; Devenish R; Fucharoen S; Svasti S
    Hemoglobin; 2016 Jun; 40(3):163-7. PubMed ID: 27117566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Epidemiological, clinico-biological, therapeutic and evolutionary aspects of β-thalassemia in Morocco].
    Zahir H; Chakour M; Mouhib H; Yahyaoui H; Ait Ameur M
    Ann Biol Clin (Paris); 2019 Apr; 77(2):169-173. PubMed ID: 30998197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Report on patients with non transfusion-dependent β-thalassemia major being treated with hydroxyurea attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013.
    Kosaryan M; Karami H; Zafari M; Yaghobi N
    Hemoglobin; 2014; 38(2):115-8. PubMed ID: 24471558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the Effect of Support-Training System of Peer Group on Promotion of Self-Care in β-Thalassemia Major Patients in Southern Iran.
    Safaei S; Abedi H; Parand S; Karimi M
    Hemoglobin; 2019 May; 43(3):198-203. PubMed ID: 31422722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemoglobinopathy carrier prevalence in the United Arab Emirates: first analysis of the Dubai Health Authority premarital screening program results.
    Belhoul KM; Abdulrahman M; Alraei RF
    Hemoglobin; 2013; 37(4):359-68. PubMed ID: 23647352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distribution of thalassemias and associated hemoglobinopathies identified by prenatal diagnosis in Taiwan.
    Peng CT; Liu SC; Peng YC; Lin TH; Wang SJ; Le CY; Shih MC; Tien N; Lu JJ; Lin CY
    Blood Cells Mol Dis; 2013 Oct; 51(3):138-41. PubMed ID: 23689197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.